Sanofi

Global pharmaceutical company. Represented by Mike Quigley at Session I.

Strategy at SDDS 2026

Constellation view: maps biologies across therapeutic areas (not within them), with immunoscience as the recurring core node — overlapping immunologic pathways with broad cross-TA applicability
Complement pathway as worked example: multiple intervention nodes across rare blood disorders, ophthalmology, neurologic disease
Capital allocation as strategy: concentration vs. diversification, build vs. buy vs. partner, ecosystem approach including a biotech-like internal incubator and China as a de-risking accelerator

Built an agentic AI workflow proposing real-time decisions across internal pipeline, Sanofi Ventures, Sanofi Capital, and BD/M&A
AI-driven indication-expansion engine and multi-target ID engine support the constellation view